An antigenic complex that restores ability in leprosy patients to kill Mycobacterium leprae--the probable molecular

P R Mahadevan1, P Robinson

  • 1Foundation for Medical Research, Worli, Bombay, India.

Tropical Medicine and Parasitology : Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft Fur Technische Zusammenarbeit (GTZ)
|September 1, 1990
PubMed

Insights

Delipidified cell components of Mycobacterium leprae (DCC) activate macrophages in leprosy patients. This restores their ability to recognize and kill M. leprae, suggesting DCC as a potential immunomodulatory treatment.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Leprosy, caused by Mycobacterium leprae, involves complex immune responses.
  • Macrophages play a crucial role in cell-mediated immunity against M. leprae.
  • Defective macrophage function is observed in lepromatous leprosy.

Purpose of the Study:

  • To investigate the immunomodulatory potential of delipidified cell components of Mycobacterium leprae (DCC).
  • To assess DCC's ability to restore macrophage function in lepromatous leprosy patients.
  • To explore DCC as a therapeutic strategy for enhancing anti-mycobacterial immunity.

Main Methods:

  • DCC was prepared from M. leprae.
  • Macrophages from lepromatous leprosy patients were exposed to DCC.
  • In vitro lymphocyte proliferation and lymphokine production (IL-2, IFN-gamma) were measured.
  • Macrophage activation was monitored using specific membrane markers.
  • Superoxide production by activated macrophages was assessed.

Main Results:

  • DCC presented as an antigen by macrophages induced lymphocyte proliferation and lymphokine production.
  • DCC-induced supernatant activated patient macrophages, altering membrane markers.
  • Activated macrophages recognized M. leprae and produced superoxide.
  • Phagocytosed M. leprae were killed by activated macrophages.

Conclusions:

  • DCC acts as a potent immunomodulator in leprosy patients.
  • DCC restores phagocyte function, enabling M. leprae killing.
  • DCC holds promise for restoring cell-mediated immunity in lepromatous leprosy.

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...